ANI Pharmaceuticals Inc (ANIP)
ANI Pharmaceuticals, Inc. is a biopharmaceutical company whose common stock trades on the NASDAQ under the symbol ANIP. The company develops, manufactures, and markets branded and generic pharmaceutical products in the United States and international markets. Its portfolio includes injectable medicines, softgel capsules, Cortrophin gel, ILUVIEN, and YUTIQ, along with a range of manufactured dosage forms such as oral solids, semi-solids, liquids, topicals, controlled substances, and potent products. ANI supplies its products through national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order pharmacies, group purchasing organizations, hospitals, and other healthcare providers. Founded in 2001, the company is headquartered in Baudette, Minnesota.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ANIP
|
$104.46
|
33.5% Upside
|
Undervalued
|
$110
|
40.6% Upside
|
Undervalued
|
Great
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
19.8x
|
3.0x
|
1.8x
|
1.648 B
|
1.967 B
|
27.7%
|
91.6%
|
3.3
|
0.8%
|
227.8%
|
